Buscar
Mostrando ítems 31-40 de 421
Functional and Structural Evaluation of Sildenafil in a Rat Model of Acute Retinal Ischemia/Reperfusion Injury
(Taylor & Francis Inc, 2017-01-01)
Purpose: Retinal ischemia is a common cause of visual impairment and blindness. Sildenafil, a PDE5 inhibitor which inhibits cGMP degradation and in turn prolongs the effect of nitric oxide, has been shown to be protective ...
Resposta imune na medula óssea e perfil hematológico de cães com Leishmaniose visceral
(Universidade Estadual Paulista (Unesp), 2013-12-05)
A avaliação da medula óssea e das células do sangue em cães com leishmaniose visceral (LV) pode proporcionar valiosas informações, tanto quantitativas quanto qualitativas, relativas à hematopoiese. Os objetivos deste estudo ...
Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
(Biomed Central Ltd., 2009-03-23)
Background: HER-2 gene testing has become an integral part of breast cancer patient diagnosis. The most commonly used assay in the clinical setting for evaluating HER-2 status is immunohistochemistry (IHC) and fluorescence ...
Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
(Biomed Central Ltd., 2009-03-23)
Background: HER-2 gene testing has become an integral part of breast cancer patient diagnosis. The most commonly used assay in the clinical setting for evaluating HER-2 status is immunohistochemistry (IHC) and fluorescence ...
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
(Associação Brasileira de Divulgação Científica (ABRADIC), 2013-03-19)
Human epidermal growth factor receptor 2 (HER2) has been evaluated in breast cancer patients to identify those most likely to benefit from herceptin-targeted therapy. HER2 amplification, detected in 20-30% of invasive ...
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
(Associação Brasileira de Divulgação Científica (ABRADIC), 2013-03-19)
Human epidermal growth factor receptor 2 (HER2) has been evaluated in breast cancer patients to identify those most likely to benefit from herceptin-targeted therapy. HER2 amplification, detected in 20-30% of invasive ...